Allopurinol, a drug normally prescribed for gout, is being used to test for
tumours in patients at high risk of developing cancer due to genetic or
environmental factors. Developed by researchers at Johns Hopkins University in
Baltimore, Maryland, the test uses allopurinol to temporarily slow DNA
production in cancer cells, causing some components of DNA—called
pyrimidines—to accumulate in the blood. These can be detected in the
patient’s urine.
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
A quantum state that lasts forever may finally be within our grasp
2
The secrets to keeping your brain sharp in old age
3
Can prebiotics, probiotics or postbiotics help your ageing microbiome?
4
Has the answer to life's origins been hiding in our cells all along?
5
Almost the whole of Japan moved eastward after 2011 earthquake
6
Remarkable fossils rewrite the story of how animals conquered the land
7
Carl Sagan's The Demon-Haunted World is still supremely relevant today
8
Our brains have their first thoughts surprisingly early in life
9
Autism may have two distinct subtypes that vary by brain activity
10
91av recommends an excellent look at the future of work
